MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net$10,665K Net proceeds fromdecember 2025 private...$3,544K Proceeds from promissorynote, net of original...$3,000K Net cash provided byfinancing activities$17,043K Effect of exchange ratechanges on cash and cash...$49K Canceled cashflow$166K Change in cash, cashequivalents, and restricted...$1,756K Canceled cashflow$15,336K Series a warrantrepurchase$166K Change in fair value ofderivative liability-$3,267K Increase in accountspayable$325K Stock-based compensation$211K Amortization of originalissue discount...$182K Issuance of restrictedshares as compensation...$122K Loss on series awarrant repurchase$99K Depreciation$42K Increase (decrease) inother current...$17K Loss on fixed assetdisposal-$16K Net cash used inoperating activities-$15,240K Net cash used ininvestment activities-$96K Canceled cashflow$4,281K Net loss-$19,388K Purchase of property andequipment$96K Decrease (increase) inother current assets$133K
Cash Flow
source: myfinsight.com

Glucotrack, Inc. (GCTK)

Glucotrack, Inc. (GCTK)